Exact Mass: 363.1307

Exact Mass Matches: 363.1307

Found 160 metabolites which its exact mass value is equals to given mass value 363.1307, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

9-Aminocamptothecin

9-Aminocamptothecin (R,S)

C20H17N3O4 (363.1219)

9-Aminocamptothecin (9-Amino-CPT) is a topoisomerase I inhibitor with potent anticancer activity 9-Aminocamptothecin. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=91421-43-1 (retrieved 2024-08-08) (CAS RN: 91421-43-1). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

(4-(2-((2-(3-Chlorophenyl)-2-hydroxyethyl)amino)propyl)phenoxy)acetic acid

2-(4-((2R)-2-(((2R)-2-(3-Chlorophenyl)-2-hydroxyethyl)amino)propyl)phenoxy)acetic acid

C19H22ClNO4 (363.1237)

D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists

4-[[5-Chloro-4-(2,4,6-trimethylanilino)pyrimidin-2-yl]amino]benzonitrile

4-({5-chloro-4-[(2,4,6-trimethylphenyl)amino]pyrimidin-2-yl}amino)benzonitrile

C20H18ClN5 (363.1251)

9-Aminocamptothecin

8-amino-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione

C20H17N3O4 (363.1219)

N-Biotinyl-4-aminobenzoic acid

4-(5-{2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl}pentanamido)benzoic acid

C17H21N3O4S (363.1253)

Biotinyl-p-aminobenzoate

5-{2-hydroxy-1H,3ah,4H,6H,6ah-thieno[3,4-D]imidazol-6-yl}pentanoyl 4-aminobenzoic acid

C17H21N3O4S (363.1253)

2-[[[4-(3-Benzylcyclobutyl)-1,3-thiazol-2-yl]diazenyl]methyl]phenol

2-({2-[4-(3-benzylcyclobutyl)-1,3-thiazol-2-yl]diazen-1-yl}methyl)phenol

C21H21N3OS (363.1405)

corytuberine

C19H21NO4.HCl (363.1237)

9-Aminocamptothecin

(19S)-8-amino-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione

C20H17N3O4 (363.1219)

9-Aminocamptothecin is a pyranoindolizinoquinoline. Aminocamptothecin has been used in trials studying the treatment of Lymphoma, Gastric Cancer, Ovarian Cancer, Esophageal Cancer, and Ovarian Neoplasms, among others. Aminocamptothecin is a water-insoluble camptothecin derivative. Aminocamptothecin binds to the nuclear enzyme topoisomerase I, thereby inhibiting repair of single-strand DNA breakages. Because the terminal lactone ring of aminocamptothecin required for the agents antitumor activity spontaneously opens under physiological conditions to an inactive carboxy form, the drug must be administered over an extended period of time to achieve effective cytotoxicity. (NCI04) C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor D000970 - Antineoplastic Agents 9-Aminocamptothecin (9-Amino-CPT) is a topoisomerase I inhibitor with potent anticancer activity[1]. 9-Aminocamptothecin. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=91421-43-1 (retrieved 2024-10-18) (CAS RN: 91421-43-1). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

A member of the class of 2,5-diketopiperazines with an indole substituent. It is a microbial metabolite isolated from the mycelia of a liquid fermentation culture of the fungus, Bionectria byssicola and has been shown to exhibit antibacterial activity against Staphylococcus aureus.